ProfileGDS4718 / 1556633_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 45% 42% 53% 47% 42% 46% 51% 44% 44% 43% 45% 45% 45% 46% 45% 44% 48% 38% 51% 40% 48% 45% 47% 49% 46% 48% 46% 52% 49% 49% 52% 48% 43% 45% 48% 52% 47% 43% 42% 52% 41% 47% 48% 48% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.2531945
GSM549102patient 115, normal, homogenized [OPG study]5.1211142
GSM549104patient 119, normal, homogenized [OPG study]5.6972553
GSM549108patient 138, normal, homogenized [OPG study]5.4016247
GSM549119patient 077, normal, homogenized [OPG study]5.1204342
GSM549133patient 032, cancer, homogenized [OPG study]5.2654146
GSM549139patient 042, cancer, homogenized [OPG study]5.5739851
GSM549099patient 107, normal, homogenized [OPG study]5.2021144
GSM549109patient 139, normal, homogenized [OPG study]5.2210444
GSM549110patient 046, normal, homogenized [OPG study]5.1261243
GSM549114patient 063, normal, homogenized [OPG study]5.2179745
GSM549122patient 082, normal, homogenized [OPG study]5.2376745
GSM549134patient 033, cancer, homogenized [OPG study]5.2325545
GSM549136patient 036, cancer, homogenized [OPG study]5.2522846
GSM549140patient 044, cancer, homogenized [OPG study]5.1844345
GSM549111patient 047, normal, homogenized [OPG study]5.1486544
GSM549113patient 057, normal, homogenized [OPG study]5.3205748
GSM549132patient 031, cancer, homogenized [OPG study]4.8987838
GSM549137patient 038, cancer, homogenized [OPG study]5.5769651
GSM549142patient 047, cancer, homogenized [OPG study]5.1104640
GSM549100patient 110, normal, homogenized [OPG study]5.4366148
GSM549107patient 135, normal, homogenized [OPG study]5.2325145
GSM549115patient 068, normal, homogenized [OPG study]5.3155847
GSM549116patient 072, normal, homogenized [OPG study]5.416249
GSM549120patient 078, normal, homogenized [OPG study]5.2909246
GSM549131patient 030, cancer, homogenized [OPG study]5.3447748
GSM549118patient 074, normal, homogenized [OPG study]5.3124146
GSM549129patient 027, cancer, homogenized [OPG study]5.6291652
GSM549123patient 088, normal, homogenized [OPG study]5.446549
GSM549124patient 006, cancer, homogenized [OPG study]5.4855249
GSM549126patient 015, cancer, homogenized [OPG study]5.6227852
GSM549128patient 025, cancer, homogenized [OPG study]5.3670648
GSM549103patient 117, normal, homogenized [OPG study]5.2106343
GSM549117patient 073, normal, homogenized [OPG study]5.1786345
GSM549138patient 041, cancer, homogenized [OPG study]5.3964648
GSM549141patient 045, cancer, homogenized [OPG study]5.6227252
GSM549130patient 028, cancer, homogenized [OPG study]5.3319847
GSM549101patient 111, normal, homogenized [OPG study]5.1891843
GSM549105patient 128, normal, homogenized [OPG study]5.1151742
GSM549106patient 134, normal, homogenized [OPG study]5.5974352
GSM549112patient 048, normal, homogenized [OPG study]5.0095641
GSM549125patient 011, cancer, homogenized [OPG study]5.3390847
GSM549127patient 024, cancer, homogenized [OPG study]5.4011948
GSM549135patient 035, cancer, homogenized [OPG study]5.3501748